Company Filing History:
Years Active: 2014
Title: Ariadna Cuevas Fiallo: Innovator in Vaccine Development
Introduction
Ariadna Cuevas Fiallo is a notable inventor based in Havana, Cuba. She has made significant contributions to the field of immunology, particularly in the development of vaccine compositions for cancer treatment. Her innovative approach has the potential to enhance therapeutic options for patients suffering from tumors.
Latest Patents
Ariadna holds a patent for a "Method for making a homogenous vaccine composition comprising a conjugate of EGF and 64K for the treatment of tumors." This vaccine composition is designed for therapeutic use in cancer patients and includes a chemical conjugate of human recombining Epidermic Growth Factor (hrEGF) and a combining protein P64k. The conjugation reaction produces this chemical conjugate in a controlled and reproducible manner. The preferred conjugate surprisingly increases immunogenic activity, leading to significant increases in anti-EGF antibody titers in humans. This innovative vaccine preparation offers multiple effective dose presentations, allowing for increased immunization doses per patient without raising the frequency of immunizations or the number of immunization sites.
Career Highlights
Ariadna is affiliated with the Centro de Inmunología Molecular (CIM), where she continues her research and development efforts. Her work is pivotal in advancing cancer treatment options through innovative vaccine technologies.
Collaborations
Some of her coworkers include Gryssell Rodriguez Martinez and Lisel Vina Rodriguez, who contribute to her research endeavors and collaborative projects.
Conclusion
Ariadna Cuevas Fiallo's contributions to vaccine development represent a significant advancement in cancer treatment. Her innovative methods and dedication to research continue to inspire progress in the field of immunology.